DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Lievre A et al.
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.
J Clin Oncol 2008;
26 (03) 374-379
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.